Family Medicine Doctors in Waterloo, IA Accepting Medicare

91 Family Medicine doctors found. Showing 81 - 91

Andrew Robert Green Luke, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2710 Saint Francis Dr Ste 210, Waterloo, IA 50702 Phone: 319-272-5000

Peter Nelson Rosen, APN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 E 5th St Ste 202, Waterloo, IA 50703 Phone: 319-209-4117

Dr. Jeffrey David Wilkins, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1825 Logan Ave, Waterloo, IA 50703 Phone: 319-235-3697    Fax: 319-235-3698

Travis Morstorf, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2055 Kimball Ave Ste 101, Waterloo, IA 50702 Phone: 319-272-2112

Amjed Katmeh, Family Medicine Medicare: Medicare Enrolled Practice Location: 2055 Kimball Ave Ste 101, Waterloo, IA 50702 Phone: 319-272-2112

Nura Sharma, Family Medicine Medicare: Medicare Enrolled Practice Location: 2500 Kimball Ave, Suite101, Waterloo, IA 50702 Phone: 319-272-2529    Fax: 319-272-2527

Dr. Mark L Bickley, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2710 Saint Francis Dr, Suite 210, Waterloo, IA 50702 Phone: 319-272-5000    Fax: 319-272-5282

David J Hagedorn, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2101 Kimball Avenue, Suite 401, Waterloo, IA 50702 Phone: 319-272-2002    Fax: 319-272-2071

Dr. Aralis Fuentes Martinez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2055 Kimball Ave Ste 101, Waterloo, IA 50702 Phone: 319-272-2112

Ajay Rajagopalan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2055 Kimball Ave Ste 101, Waterloo, IA 50702 Phone: 319-272-2112

Robert Stephen Pranger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Southbrooke Dr, Waterloo, IA 50702 Phone: 319-236-7751    Fax: 319-236-7753

News Archive

MabCures develops monoclonal antibodies against Colorectal Cancer

MabCure, Inc., a biotechnology company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has reached another development milestone, with the creation of its MAbs against Colorectal Cancer (CRC). After further characterization the company plans to explore the utility of these MAbs in terms of both the early diagnosis of CRC (in blood or feces specimens), as well as imaging agents for detecting micrometastatic disease during surgery and the detection of cancerous polyps during colonoscopy.

Winners of "Passion & Results" Award announced by Instrumentation Laboratory

Instrumentation Laboratory (IL) today announced the three recipients of their "Passion & Results" Award. The winners were presented with their awards by IL during ceremonies at the Congress for the International Society on Thrombosis and Haemostasis (ISTH) held in Boston, MA, July 11-16 and at the Annual Meeting for the American Association for Clinical Chemistry (AACC), in Chicago, IL, July 19-23.

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

ACS 243rd National Meeting & Exposition to be held March 25-29

Journalists may now register and reserve housing for a scientific conference that news media accounts have termed the "World Series of Science." One of the largest scientific conferences of the year, it is the American Chemical Society (ACS) 243rd National Meeting & Exposition. More than 14,000 scientists and others are expected for the event. It will be held March 25-29, 2012, in San Diego, Calif., at the San Diego Convention Center and area hotels.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3
• 4
• 5(current)